Singulair Paed Tab 5Mg 28'S

KD 11.520
Singulair is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short-acting ß-agonists provide inadequate clinical control of asthma. (Please consult your physician before taking any medication)
 
Copyright © Al Mutawa Pharmacies, Inc. All rights reserved.